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Abstract
Objectives: Preventable neonatal mortality due to tetanus infection remains common. We aimed to examine antenatal
vaccination impact in a context of continuing high neonatal mortality in rural northern India.
Methods and Findings: Using the third round of the Indian National Family Health Survey (NFHS) 2005–06, mortality of
most recent singleton births was analysed in discrete-time logistic model with maternal tetanus vaccination, together with
antenatal care utilisation and supplementation with iron and folic acid. 59% of mothers reported receiving antenatal care,
48% reported receiving iron and folic acid supplementation and 68% reported receiving two or more doses of tetanus
toxoid (TT) vaccination. The odds of all-cause neonatal death were reduced following one or more antenatal dose of TT with
odds ratios (OR) of 0.46 (95% CI 0.26 to 0.78) after one dose and 0.45 (95% CI 0.31 to 0.66) after two or more doses. Reported
utilisation of antenatal care and iron-folic acid supplementation did not influence neonatal mortality. In the statistical
model, 16% (95% CI 5% to 27%) of neonatal deaths could be attributed to a lack of at least two doses of TT vaccination
during pregnancy, representing an estimated 78,632 neonatal deaths in absolute terms.
Conclusions: Substantial gains in newborn survival could be achieved in rural North India through increased coverage of
antenatal TT vaccination. The apparent substantial protective effect of a single antenatal dose of TT requires further study. It
may reflect greater population vaccination coverage and indicates that health programming should prioritise universal
antenatal coverage with at least one dose.
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Introduction
Neonatal tetanus is an important preventable cause of neonatal
mortality. Estimates from the year 2000 of the distribution of
direct causes of death indicate that the infection accounts for 7%
of neonatal deaths worldwide [1]. Despite a considerable global
mortality decline over the last two decades, continued high
incidence in some countries results in a continued high burden of
deaths, with an estimated 130,000 newborn deaths in the year
2004 from neonatal tetanus [2]. Most of these deaths occur in a
limited number of populous countries such as India and Nigeria
[3,4] that have not yet managed to assure comprehensive health
cover especially to rural communities. In the South East Asia
Region, WHO has attributed 4% of the neonatal deaths to
neonatal tetanus [5]. A recent systematic review estimated that
neonatal tetanus contributed to between zero and 21% of the all
neonatal deaths in India [6].
In India, a recent study of newborn infections projected to the
population level indicated that neonatal infections alone accounted
for 270,000 (250,000 to 290,000) neonatal deaths [7]. Within the
country however the main mortality burden is concentrated in the
northern states [8]. Estimates from 2008 suggest that 56% of
deaths in India due to neonatal tetanus occurred in the northern
states of Rajasthan, Uttarakhand, Uttar Pradesh, Madhya
Pradesh, Chattisgarh, and Jharkhand. Of these the state of Uttar
Pradesh alone contributed 28% of the deaths and Rajasthan 16%
[9]. Strikingly, the relative contribution of the northern states to
India’s tetanus mortality burden has tripled during the last two
decades, rising from 18% in 1999 to 56% in 2008 [9,10]. Two
studies from northern India give widely differing estimates of the
burden of neonatal tetanus, from four to 38% of the total [11,12].
As these are the states that bear the maximum burden of infant
and child mortality in India [13], understanding the actual
contribution of neonatal tetanus to overall mortality and any
associations is a public health priority.
As case fatality rates for neonatal tetanus are very high the
programmatic emphasis has been on prevention through hygienic
birth practices but most importantly by a strategy of antenatal
vaccination to provide protective levels of immunity to the
newborn [14–16]. Vaccinating mothers for tetanus during
pregnancy is likely to have maximal impact in communities where
neonatal tetanus is common and where significant proportion of
deliveries takes place in unhygienic conditions and mostly attended
by untrained professionals [15]. These are typical of conditions in
rural north India where a pattern of inequalities in maternal health
care provision is seen [17].
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While the tetanus toxoid vaccination of pregnant women was
included in the WHO’s Expanded Program on Immunization
(EPI) as early as the mid-1970s and is now a standard practice
[18], the evidence base to support the mortality effect is extremely
limited. A recent systematic review yielded only one randomized
controlled trial and one well-controlled cohort study. Immuniza-
tion of pregnant women or women of childbearing age with two
doses of tetanus toxoid was estimated to reduce mortality from
neonatal tetanus by 94% [3]. However, the main limitation
identified in the review that could influence the resulting effect
estimate was the dearth of high-quality trials. This systematic
review also included the two studies listed in the Cochrane review
(‘Vaccines for women to prevent neonatal tetanus’), one from
Columbia in 1966 and the second from Bangladesh in 1980 [19].
The Bangladesh trial was originally designed to test a cholera
vaccine and tetanus toxoid was given to participants in the control
group [20]. Hence the Bangladesh trial is likely to substantially
underestimate the effect on neonatal tetanus mortality [3,19]. The
Columbia trial had a third arm containing participants that
refused vaccination and that data from this arm were not included
in the analysis [19,21]. For India, two small-scale studies examined
the effect of immunization of pregnant women with tetanus toxoid
on neonatal mortality [22,23].
We aimed to examine antenatal vaccination impact in a context
of continuing high neonatal mortality in rural northern India using
data from a statistically generalisable population sample survey.
Data and Methods
Ethics statement
This study used anonymised survey data made available for
academic use, for which ethical approval was not required.
Data
The present study uses data from the third round of the Indian
National Family Health Survey (NFHS) conducted during 2005–
2006 (NFHS 2005–06). NFHS is a nationally representative, large
scale, repeated cross sectional household survey. The principal
objective of NFHS is to provide state and national level estimates
on fertility, mortality, and family planning. The previous two
rounds of NFHS were conducted during 1992–93 and 1998–99.
The survey adopted a two-stage sample design in most rural areas
and a three-stage sample design in most urban areas. In rural
areas, the villages were selected at the first stage using a Probability
Proportional to Size (PPS) sampling scheme. The required number
of households was selected at the second stage using systematic
sampling. In urban areas, blocks were selected at the first stage,
census enumeration blocks (CEB) containing approximately 150–
200 households were selected at the second stage, and the required
number of households were selected at the third stage using a
systematic sampling technique. NFHS-3 collected information
from 109,041 households and 124,385 women aged 15–49 years.
The details of the survey design and implementation are given in
the NFHS 2005–06 report [24].
This analysis is based on most recent singleton births to women
from the rural northern region of India during the five years
preceding the NFHS 2005–06. The northern region includes
Rajasthan, Uttarakhand, Uttar Pradesh, Madhya Pradesh,
Chattisgarh, Bihar and Jharkhand. This is due to the fact that
data on antenatal care in NFHS 2005–06 were collected only for
the most recent birth. Since NFHS 2005–06 uses a multistage
sampling design, sampling weights are required to make the
estimates representative. We used appropriate sampling weights
for generating bivariate results presented in the paper. The details
of the sampling weight can be obtained from the NFHS 2005–06
report [24].
The NFHS 2005–06 can be obtained free of cost for research
purposes from the International Institute for Population Sciences
Mumbai on request. This dataset can also be obtained from
MEASURE DHS on request. The details about accessing data from
MEASURE DHS are available on their website (http://www.
measuredhs.com/data/Access-Instructions.cfm). For this analysis,
we obtained the NFHS 2005–06 data from the International
Institute for Population Sciences Mumbai.
Outcome variable
The outcome variable of interest was neonatal mortality which
is defined as the death of a live born baby within 28 days. The
information on age at death for the live births taken place in five
years preceding the NFHS 2005–06 was utilized to create the
outcome variable.
Exposure and control variables
The key exposure variables included any reported antenatal
visit (ANC), iron and folic acid supplement (IFA) and doses of
tetanus toxoid vaccinations (TT). Other variables controlled for in
the discrete-time logistic regression model were skilled attendance
at delivery, size of the newborn at birth (smaller than average,
average, larger than average), sex of the neonate (male, female)
and birth interval. The categories for birth interval were first birth
order, second or third child and birth interval less than 24 months,
second or third child and birth interval .=24 months, fourth or
higher child and birth interval ,24 months, fourth or higher child
and birth interval .=24 months. Mother’s age at birth (less than
20 years, 20–30 years, greater than 30 years), wealth quintiles
(poorest, poorer, middle, richer, richest), religion (Hindu, Muslim,
others), caste (Scheduled castes/tribes (SC/ST), other backward
classes (OBC), others), and mother’s education (non-literate,
schooling upto middle school, middle school and higher) were
also included in the models. Caste is a hereditary, endogamous,
usually localised group, having a traditional association with an
occupation, and a particular position in local hierarchy [25]. The
scheduled castes/tribes and other backward classes are socially
and economically less developed compared to the ‘other castes’.
So, the Government of India has implemented a number of
affirmative actions to improve the socio-economic status of these
castes.
Statistical analysis
We use multivariate discrete-time logistic model to examine the
relationship between ANC use, IFA supplementation, and TT
vaccination during pregnancy with the risk of neonatal mortality,
after adjusting for other control variables. The outcome variable
for the discrete-time logistic model was the binary indicator of
occurrence of neonatal death. A number of recent studies have
used this approach to model neonatal mortality [26–27]. As a
model building strategy, we first fitted bivariate models for the
association between each possible exposure/control variable and
neonatal mortality. All the variables that were significant in the
bivariate models (at a conservative p,.2) were included in the
multivariable model. All the independent variables were tested for
possible multi-collinearity before putting them into the discrete-
time logistic regression model. The odds ratio and the 95%
confidence interval (CI) for neonatal death were estimated for each
factor. Having found a significant relationship between TT
vaccination during pregnancy and risk of neonatal mortality, we
further estimated the population attributable risk (PAR). The PAR
is given by
Tetanus Toxoid Vaccination and Neonatal Mortality
PLOS ONE | www.plosone.org 2 November 2012 | Volume 7 | Issue 11 | e48891
PAR~w|
(aHR{1)
aHR
where w=proportion of women who did not receive .=2 tt
aHR=adjusted hazard ratio for neonatal death in neonates born
to women who did not receive .=2 tt
Finally, we used binary logistic regression model to examine the
factors associated with the utilization of two or more doses of TT
vaccination during pregnancy. We used STATA 11.0 for statistical
computations. All the independent variables were tested for
possible multi-collinearity before putting them into the regression
models.
Results
In the five years preceding the survey round, there were 8,474
singleton most recent births. Of these 258 resulted in neonatal
death. 59% of mothers reported receiving any form of antenatal
care during their most recent pregnancy. 48% of mothers reported
receiving iron and folic acid supplementation. Twenty-seven
percent of mothers did not report receiving any tetanus toxoid
vaccination during their most recent pregnancy. About two-thirds
of mothers received two or more than two doses of tetanus toxoid
(Table 1). Interestingly, only 25% of the recent births were
supervised trained medical professionals. Approximately 15% of
the recent births occurred to mothers who were less than 20 years
of age. About 18% of births occurred to mothers who were above
30 years of age. Fifty-eight percent of births were of average size at
birth and about 20% were of size larger than average.
Discrete-time logistic regression results adjusted for socio-
economic, demographic, and health service delivery variables
are presented in Table 2. Antenatal care provision and uptake of
iron and folic supplements were not significantly associated with
neonatal mortality. However, maternal tetanus vaccination was
significantly and negatively associated with neonatal mortality: the
odds of all-cause neonatal death were reduced following one or
more antenatal dose of TT with odds ratios (OR) of 0.46 (95% CI
0.26 to 0.78) after one dose and 0.45 (95% CI 0.31 to 0.66) after
two or more doses.
Table 1. The prevalence of pregnancy health-care services provided to mothers and other birth related characteristics of infants
born in five years preceding NFHS 3, rural northern India{, 2005–06.
Pregnancy health-care service and other birth related characteristics % N (weighted)
Antenatal care
No Antenatal care 41.3 3499
Availed antenatal care 58.7 4975
Iron folic acid supplements
None 52.3 4434
Received 47.7 4043
Tetanus toxoid vaccination
None 27.4 2320
1 injection 7.8 663
.= 2 injections 64.8 5495
Type of supervision at birth
Untrained 74.8 6344
Trained 25.2 2136
Mother’s age at birth
,20 years 14.8 1253
20–30 years 67.0 5687
.30 years 18.2 1542
Size of the newborn at birth
Smaller than average 22.6 1919
Average 57.6 4886
Larger than average 19.8 1675
Birth interval
First birth 20.2 1713
2nd/3rd birth and birth interval ,24 months 10.2 870
2nd/3rd birth and birth interval .= 24 months 27.9 2365
4th/higher birth and birth interval ,24 months 9.4 795
4th/higher birth and birth interval .= 24 months 32.3 2739
Total 100.0 8482
Note:
{includes Rajasthan, Uttaranchal, Uttar Pradesh, Madhya Pradesh, Chattisgarh, Bihar, and Jharkhand.
The total number varies between categories because some values are missing.
doi:10.1371/journal.pone.0048891.t001
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Considering the plausible association between tetanus toxoid
vaccination during pregnancy and neonatal mortality, we com-
puted the population attributable risk (PAR). The PAR indicates
that 16% of the neonatal deaths in rural northern India could be
attributed to a lack of at least two doses of tetanus toxoid
vaccination during pregnancy (PAR 0.16; 95% CI 0.05 to 0.27).
Type of supervision at birth was significantly associated with
neonatal mortality in rural northern India. The odds of neonatal
deaths were significantly higher among the deliveries supervised by
trained professionals compared to those supervised by friends/
relatives (OR: 1.52; 95% CI: 1.13–2.03). Second and third order
births had significantly lower risk of neonatal mortality compared
to the first order births. Likewise, babies of average size at the time
of birth had significantly lower risk of neonatal mortality
compared to babies that were smaller than average at the time
of birth (OR: 0.67; 95% CI: 0.50–0.88). Interestingly, mother’s
age at the birth of the newborn was not associated with neonatal
mortality when the results were adjusted for other exposure and
control variables.
Finally, we examined factors associated with tetanus toxoid
vaccination during pregnancy (Table 3). Mother’s education,
mother’s age at birth of the index child and wealth status of the
household were significantly associated with provision of at least
two doses of antenatal tetanus vaccination, with educated and
better-off mothers significantly more likely to receive at least two
doses. Interestingly, mothers who were older than 20 years at the
birth of index child were significantly less likely to receive
vaccination (OR 0.78 and 0.50 for mothers aged 20–30 years
and mothers aged more than 30 years, respectively). Muslim
mothers were 0.85 (95% CI: 0.73, 0.98) times as likely as Hindu
mothers to avail tetanus toxoid vaccination.
Discussion and Conclusions
Results adjusted for socio-economic, demographic and health
system related variables such as antenatal care and iron folic
supplementation show a substantial protective impact of antenatal
vaccination on neonatal mortality. The present findings are
consistent with observational data from demographic surveillance
settings [28] and those from a study that examined the
determinants of neonatal mortality in a similar grouping of Indian
states using a combination of sample registration and population
survey data, where neonatal mortality was lower by 30% for
Table 2. Discrete-time logistic regression results for neonatal mortality, rural northern India{, 2005–06.
Pregnancy health-care service and other birth related characteristics Odds ratio (95% CI) p-value
Antenatal care
No Antenatal care (reference)
Availed antenatal care 1.19 (0.83,1.73) 0.343
Iron folic acid supplements
None (reference)
Received 1.19 (0.86,1.64) 0.291
Tetanus toxoid vaccination
None (reference)
1 injection 0.46 (0.26,0.78) 0.005
.= 2 injections 0.45 (0.31,0.66) 0.000
Type of supervision at birth
Untrained (reference)
Trained 1.52 (1.13,2.03) 0.005
Mother’s age at birth
,20 years (reference)
20–30 years 1.22 (0.83,1.80) 0.312
.30 years 1.47 (0.87,2.50) 0.153
Size of the newborn at birth
Smaller than average (reference)
Average 0.67 (0.50,0.88) 0.005
Larger than average 0.79 (0.55,1.14) 0.211
Birth interval
First birth (reference)
2nd/3rd birth and birth interval ,24 months 0.47 (0.28,0.77) 0.003
2nd/3rd birth and birth interval .= 24 months 0.37 (0.25,0.55) 0.000
4th/higher birth and birth interval ,24 months 0.95 (0.61,1.47) 0.814
4th/higher birth and birth interval .= 24 months 0.31 (0.20,0.48) 0.000
Note:
{includes Rajasthan, Uttaranchal, Uttar Pradesh, Madhya Pradesh, Chhattisgarh, Bihar, and Jharkhand.
CI – confidence interval.
Control variables included wealth quintiles, religion, caste, mother’s education, and sex of the newborn.
doi:10.1371/journal.pone.0048891.t002
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children of mothers who received at least two doses of tetanus
toxoid during pregnancy [29]. Our findings suggest that 16% of
the neonatal deaths in rural northern India can be attributed to
lack of at least two doses of tetanus toxoid vaccination during
pregnancy.
The present findings should be interpreted in the context of
stagnation of the decline in infant mortality in India in the recent
past at unacceptably high levels for most of the states in the
country [30] but especially in the Northern states. Policy initiatives
have included Janani Suraksha Yojana, where women are paid cash
incentives for delivering their babies in public health facilities or
government-designated private facilities [31]. Delivery in a health
facility is likely to contribute substantially to newborn survival
(including tetanus prevention) through provision of hygienic
delivery conditions and the ability to provide immediate newborn
care. While the Government of India has been promoting
antenatal care under the Reproductive and Child Health (RCH)
Programme and the National Rural Health Mission [32], these
programmes have several components that require the attention of
health workers and it is possible that the crucial importance of
achieving universal antenatal tetanus vaccination has not received
sufficient emphasis.
The present findings are consistent with the presence of a
substantial protective effect of a single antenatal dose of tetanus
toxoid. The PAR indicates that 20% of the neonatal deaths in
rural northern India could be attributed to a lack of at least one
dose of tetanus toxoid vaccination during pregnancy (PAR 0.20;
95% CI 0.11 to 0.29). Two or more doses are generally
recommended in order to assure high protective antibody titres.
The unexpectedly substantial protective effect of a single dose
requires explanation. It is possible that public health interventions
including childhood vaccination of mothers through the EPI
programme implemented by the WHO as early as 1970s’ and
reproductive health programmes that include tetanus vaccination
of women in the reproductive age group have led to a higher
proportion of north Indian women who have had prior
vaccination and hence respond more vigorously to what is
effectively a ‘booster’ single dose of vaccine given antenatally.
Alternatively, there may have been advances in vaccine manufac-
ture, storage and distribution logistics that have resulted in a
higher immunological response. Further studies are needed to
elucidate the biological basis of the present findings.
Interestingly, the supervised births had higher risk of neonatal
mortality compared to the unsupervised births in rural northern
India. The plausible reason for this type of finding is that in rural
northern India, it is only the risky births or deliveries with
complications that tend to take place under supervision of
medically qualified professional. This is also obvious from the
finding that only 25% of the recent births were delivered under the
supervision of a medically qualified professional in rural northern
India. Some other Indian studies have also reported similar
findings [33].
The socio-economic component of the modelling indicates that
poor, older, and Muslim women are significantly less likely to
receive the recommended doses of tetanus toxoid vaccination.
This is consistent with the findings of other studies that also
document that older women are less likely than younger women to
utilize antenatal and delivery care in the country [34–36]. These
are also the women who are less likely to make use of other services
such as skilled attendance at delivery, and schemes like Janani
Suraksha Yojana [24,31,37]. Although, the National Rural Health
Mission has a mandate to make quality health care accessible to
all, particularly to the poor and the marginalized, our findings
along with others clearly show that it is the poor and the
marginalized who are still out of the reach of government-
sponsored public health programmes [32]. These are the groups
that bear the maximum burden of neonatal and infant mortality in
the country. From the present findings, a policy and programming
imperative to assure provision of at least a single antenatal dose to
all, especially those in marginalised or disadvantaged population
subgroups, is likely to achieve substantial impact on improving
newborn survival. Relative to the complexities of providing the full
health system functionality required for comprehensive and safe
maternal and newborn care, this specific intervention should be
within the reach of the public health system as an immediate
priority.
The large sample size allowed the examination of health-care
interventions and neonatal mortality, after adjusting for a range of
other variables known to be associated with neonatal mortality.
The focus on most recent singleton births in the analysis helped us
to avoid recall bias on the part of mothers included in the study.
However, limitations of the present study must be acknowledged.
As the protective effects of tetanus last long – more than three-
quarters of women will maintain ‘protective levels’ for 3 years
[3,38], an analysis based only on first births would have yielded
more information. We could not base our multivariate analysis
Table 3. Binary logistic regression analysis results for factors
affecting utilization of two or more tetanus toxoid
vaccinations, rural Northern India{, 2005–06.
Covariate & category Odds ratio (95% CI) p-value
Mother’s education
Non-literate (reference)
Schooling up to middle school 1.94 (1.71,2.20) 0.000
Middle school and higher 3.58 (2.79,4.58) 0.000
Mother’s age at birth of index
child
Less than 20 years (reference)
20–30 years 0.78 (0.68,0.90) 0.001
Greater than 30 years 0.50 (0.42,0.59) 0.000
Caste
Scheduled castes/tribes (reference)
Other backward classes 1.29 (1.16,1.44) 0.000
Others 0.95 (0.81,1.12) 0.564
Religion
Hindu (reference)
Muslim 0.85 (0.73,0.98) 0.031
Others 0.83 (0.61,1.13) 0.237
Wealth quintiles
Poorest (reference)
Poorer 1.40 (1.25,1.57) 0.000
Middle 1.68 (1.46,1.94) 0.000
Richer 2.49 (2.04,3.04) 0.000
Richest 5.95 (3.83,9.26) 0.000
Type of household
Nuclear (reference)
Non-nuclear 1.06 (0.96,1.17) 0.244
{includes Rajasthan, Uttaranchal, Uttar Pradesh, Madhya Pradesh, Chattisgarh,
Bihar, and Jharkhand.
CI – confidence interval.
doi:10.1371/journal.pone.0048891.t003
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only on first births due to the small sample size and relatively small
numbers of neonatal deaths. Secondly we could not validate the
information provided by the women for example by cross
reference to clinic records or biomarkers such as tetanus antibody
levels. However it should be noted that the survey format has been
regularly used in the various rounds of NFHS and the findings are
widely used to monitor the performance of policies and
programmes in India [39]. Survey teams receive formal training
and quality control measures are in place. Also, findings from
other similar large-scale surveys in India such as the District Level
Household Surveys (DLHS) [37] – provide some cross reference to
the credibility of information provided in NFHS 3. Thirdly, we
could not estimate the extent to which the childhood vaccination
of mothers (especially the younger ones) against six vaccine
preventable diseases could have resulted into overestimation of the
potential impact of one dose of tetanus toxoid vaccination during
pregnancy. This is because the information on childhood
vaccinations was not available for the mothers of the neonates.
In cross-sectional surveys, one cannot rule out the possibility of
underreporting of maternal tetanus toxoid vaccination by mothers
whose infants had died during the neonatal period. However, this
possibility is minimal in NFHS 2005–06 because the information
on neonatal mortality was collected in the birth history section,
whereas the information on maternal tetanus toxoid vaccinations
was collected in the antenatal care section. It is also important to
note that these two sections were well spaced out in the interview
schedule.
Using population estimates from the ‘Population Projection for
India and States 2001–2026’[40] and the population attributable
risk estimated in the present study, we estimate that 78,632
(confidence bound: 24,573–132,692) neonatal deaths could be
prevented in rural northern India every year by universal
provision of at least two antenatal tetanus toxoid vaccination.
Our findings, therefore, call for greater focus on increasing access
to tetanus toxoid in rural northern India within a context of
greater attention on the poor and the marginalized if India is to
achieve the Millennium Development Goal 4 [41].
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